Trial · NCT02553317
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Treatment Period + Follow-up | STARTED | Caplacizumab | 72 | |
| Overall Treatment Period + Follow-up | STARTED | Placebo | 73 | |
| Overall Treatment Period + Follow-up | Received Study Drug | Caplacizumab | 71 | |
| Overall Treatment Period + Follow-up | Received Study Drug | Placebo | 73 | |
| Overall Treatment Period + Follow-up | COMPLETED | Caplacizumab | 58 | |
| Overall Treatment Period + Follow-up | COMPLETED | Placebo | 50 | |
| Overall Treatment Period + Follow-up | NOT COMPLETED | Caplacizumab | 14 | |
| Overall Treatment Period + Follow-up | NOT COMPLETED | Placebo | 23 | |
| Double-blind (DB) Treatment Period | STARTED | Caplacizumab | 71 | |
| Double-blind (DB) Treatment Period | STARTED | Placebo | 73 | |
| Double-blind (DB) Treatment Period | COMPLETED | Caplacizumab | 68 | |
| Double-blind (DB) Treatment Period | COMPLETED | Placebo | 65 | |
| Double-blind (DB) Treatment Period | NOT COMPLETED | Caplacizumab | 3 | |
| Double-blind (DB) Treatment Period | NOT COMPLETED | Placebo | 8 | |
| Open-label (OL) Treatment Period | STARTED | Caplacizumab | 2 | |
| Open-label (OL) Treatment Period | STARTED | Placebo | 26 | |
| Open-label (OL) Treatment Period | COMPLETED | Caplacizumab | 2 | |
| Open-label (OL) Treatment Period | COMPLETED | Placebo | 22 | |
| Open-label (OL) Treatment Period | NOT COMPLETED | Caplacizumab | 0 | |
| Open-label (OL) Treatment Period | NOT COMPLETED | Placebo | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02553317/flow